Monitoring M-Protein Levels in Multiple Myeloma Using Microsampling Devices Coupled With Intact Mass High-Resolution Mass Spectrometry

Posters Nov 19, 2024

Oncology

Mass Spectrometry

November 19, 2024

Luca Genovesi

Monitoring M-Protein Levels in Multiple Myeloma Using Microsampling Devices Coupled With Intact Mass High-Resolution Mass Spectrometry

EBF 2024

Posters

Apr 14, 2026

Understanding Protein Normalization: A Case Study in PBMC Fit-for-Purpose Validation by MS

Posters

Mar 3, 2026

Challenging Hybrid Affinity Approach: Streamlined Total Antibody Quantitation with Uncompromised Sensitivity

Posters

Mar 3, 2026

Patient-Centric Measurement of M-Protein Using High-Resolution Intact Mass Spectrometry

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.

Monitoring M-Protein Levels in Multiple Myeloma Using Microsampling Devices Coupled With Intact Mass High-Resolution Mass Spectrometry

Featured Resources

Understanding Protein Normalization: A Case Study in PBMC Fit-for-Purpose Validation by MS

Challenging Hybrid Affinity Approach: Streamlined Total Antibody Quantitation with Uncompromised Sensitivity

Patient-Centric Measurement of M-Protein Using High-Resolution Intact Mass Spectrometry

One global CRO for your whole therapeutic development journey